The role of chromosomally encoded toxin-antitoxin (TA) loci in bacterial physiology has been under debate, with the toxin proposed as either an inducer of bacteriostasis or a mediator of programmed cell death (PCD). We report here that ectopic expression of MazF Sa , a toxin of the TA module from Staphylococcus aureus, led to a rapid decrease in CFU counts but most cells remained viable as determined by differential Syto 9 and propidium iodide staining after MazF Sa induction. This finding suggested that the toxin MazF Sa induced cell stasis rather than cell death. We also showed that MazF Sa selectively cleaves cellular mRNAs in vivo, avoiding "important" transcripts such as recA, gyrB, and sarA mRNAs in MazF Sa -induced cells, while these three mRNAs can be cleaved in vitro. The results of Northwestern blotting showed that both sarA and recA mRNAs bind strongly to a putative RNA-binding protein. These data suggest that S. aureus likely undergoes stasis by protecting selective mRNA with RNA-binding proteins upon the expression of MazF Sa in vivo.Many bacteria have chromosomally encoded toxin-antitoxin (TA) loci in which the toxin and antitoxin genes exist in an operon and are coexpressed to form a TA complex. The toxin is stable, while the antitoxin is labile and can be degraded in vivo by host proteases (e.g., ClpP or Lon in Escherichia coli). Under conditions of stress whereby transcription of the TA operon is repressed and which hence preclude the continuous synthesis of the labile antitoxin, the more-stable toxin can unleash its toxic effect to inhibit cell growth. However, metabolic stresses, such as amino acid and carbon source starvation, have been shown to induce transcription of E. coli mazEF and other TA loci in E. coli (7,9,14). Studies with several toxin systems indicate that many toxins are probably sequence-specific endoribonucleases. For instance, MazF of E. coli cleaves mRNA at ACA sites both in vitro and in vivo (30), while the RelE toxin, also from E. coli, cleaves mRNA positioned at the ribosomal A site both in vitro and in vivo, with cleavage occurring between the second and third bases of the A site codon